TY  - CHAP
M1  - Book, Section
TI  - Special Populations (Children and Elderly)
A1  - Rollins, Douglas E.
A1  - Blumenthal, Donald K.
Y1  - 2016
N1  - 
T2  - Workbook and Casebook for Goodman and Gilman's The Pharmacological Basis of Therapeutics
AB  - There  is  no  specific  chapter  on  the  topic  of  pharmacotherapy  of  special  populations  (children  and  elderly)  in  Goodman  &  Gilman’s  The  Pharmacological  Basis  of  Therapeutics,  12th  Edition.  However,  this  is  an  important  area  of  clinical  pharmacology  because  the  pharmacotherapy  of  children  and  the  elderly  requires  consideration  of  the  differences  in  pharmacokinetics  and  pharmacodynamics  that  can  significantly  affect  the  safety  and  efficacy  of  drugs  used  in  these  special  populations.  Moreover,  most  randomized  controlled  clinical  trials  exclude  young  children  and  the  aged,  which  makes  it  difficult  for  the  clinician  to  make  evidence-based  decisions  regarding  appropriate  drugs  and  dosing  regimens  to  use  in  these  patients.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/19
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=1121942356
ER  -